Abbott gets FDA clearance for over-the-counter continuous glucose monitors
How are some CGM startups marketing their products to nondiabetics, and what potential benefits are they promoting?
Some CGM startups, such as Nutrisense and Levels, are marketing their products to non-diabetics by promoting potential benefits like weight loss, optimized athletic performance, and improved metabolic health. These companies suggest that using a CGM can help individuals make more informed decisions about their diet and lifestyle choices, potentially leading to better overall health and well-being. However, it is important to note that the jury is still out on how impactful CGM use is in non-diabetics, and further research is needed to validate these claims.
How do these new CGMs measure glucose levels, and why don't they measure blood sugar directly?
The new CGMs, Lingo and Libre Rio, measure glucose levels using a small wearable sensor that is typically worn for about 14 days at a time. These sensors measure glucose in the interstitial fluid, which is the fluid found between cells just under the skin, rather than measuring blood sugar directly.
The reason for measuring glucose in the interstitial fluid instead of blood sugar directly is that it allows for continuous monitoring without the need for invasive blood draws. The glucose levels in the interstitial fluid correlate with blood sugar levels, providing a less invasive and more convenient way to track glucose trends over time.
For whom is the Lingo CGM specifically designed, and what insights does it aim to provide to its users?
The Lingo CGM is specifically designed for health-conscious consumers who want to get greater insight into their metabolism. It is meant to be a "consumer wearable" for people 18 years and older. The Lingo CGM aims to provide users with coaching insights into their reactions to certain foods, exercise, and stress. It is not intended to be used to diagnose any metabolic disorders or inform diabetes treatment.